Evidence map›Paper›PMID 19706508›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Coarse-grained modeling of allosteric regulation in protein receptors.

Ilya A Balabin, Weitao Yang, David N Beratan

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cooperative dynamics of proteins unraveled by network models.Wiley interdisciplinary reviews. Computational molecular science
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ilya A BalabinDepartment of Chemistry, Duke University, Durham, NC 27708, USA. ilya.balabin@duke.edu
Weitao Yang
David N Beratan
City Of Hope National Medical Center · USDuke University · US

Funding

MAPPING OF ELECTRON TUNNELING PATHWAYS IN PROTEINSR01GM048043 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVID BERATAN · 1993 to 2026
$6.0M
COMPUTER SIMULATIONS OF ENZYMES AND DNAR01GM061870 · NIGMS · DUKE UNIVERSITY · PI YANG, WEITAO · 2000 to 2022
$5.5M
NIGMS NIH HHS GM-048043NIGMS NIH HHS GM-061870NIGMS NIH HHS R01 GM048043NIGMS NIH HHS R01 GM061870
6 · The paper itself

Abstract

Allosteric regulation provides highly specific ligand recognition and signaling by transmembrane protein receptors. Unlike functions of protein molecular machines that rely on large-scale conformational transitions, signal transduction in receptors appears to be mediated by more subtle structural motions that are difficult to identify. We describe a theoretical model for allosteric regulation in receptors that addresses a fundamental riddle of signaling: What are the structural origins of the receptor agonism (specific signaling response to ligand binding)? The model suggests that different signaling pathways in bovine rhodopsin or human beta(2)-adrenergic receptor can be mediated by specific structural motions in the receptors. We discuss implications for understanding the receptor agonism, particularly the recently observed "biased agonism" (selected activation of specific signaling pathways), and for developing rational structure-based drug-design strategies.

Indexed as

Models, TheoreticalAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AgonistsAlgorithmsAllosteric RegulationAnimalsBinding SitesCattleHumansLigandsModels, MolecularProtein ConformationProtein Structure, SecondaryProtein Structure, TertiaryReceptors, Adrenergic, beta-2RhodopsinAdrenergic beta-2 Receptor AgonistsAdrenergic beta-AgonistsLigandsReceptors, Adrenergic, beta-2Rhodopsin

Identifiers

PMID19706508
PMCPMC2732817
OpenAlexW2168002683

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.